Literature DB >> 9689237

Linguistic and cognitive deficits associated with cerebellar mutism.

D Vandeinse1, J E Hornyak.   

Abstract

Cerebellar mutism is a period of transient loss of speech following posterior fossa surgery, usually in children under 15 years of age. To date, cases presented in the literature have addressed primarily the motor speech aspect of the phenomenon, with little documentation relative to higher-level linguistic and cognitive functioning of these children. Recent research, however, is increasingly documenting evidence of cerebellar involvement in language and cognition. This paper describes four children, three of whom presented with a period of mutism following posterior fossa surgery, and one who did not exhibit mutism. All children, however, demonstrated a similar profile of significant high-level linguistic and cognitive deficit on formal speech-language and neuropsychological measures. Documented cases to date are reviewed and compared to these subjects. Literature documenting the role of the cerebellum in language and cognition is summarized and compared to evidence of residual deficits associated with cerebellar mutism as demonstrated by the children in this study.

Entities:  

Mesh:

Year:  1997        PMID: 9689237     DOI: 10.3109/17518429709060941

Source DB:  PubMed          Journal:  Pediatr Rehabil        ISSN: 1363-8491


  13 in total

1.  Long-term effects of transient cerebellar mutism after cerebellar astrocytoma or medulloblastoma tumor resection in childhood.

Authors:  Joelene F Huber; Kim Bradley; Brenda J Spiegler; Maureen Dennis
Journal:  Childs Nerv Syst       Date:  2005-09-10       Impact factor: 1.475

Review 2.  Cause and outcome of cerebellar mutism: evidence from a systematic review.

Authors:  Rosa Reed-Berendt; Bob Phillips; Susan Picton; Paul Chumas; Daniel Warren; John H Livingston; Ellen Hughes; Matthew C H J Morrall
Journal:  Childs Nerv Syst       Date:  2014-01-23       Impact factor: 1.475

3.  Heralding cerebellar mutism: evidence for pre-surgical language impairment as primary risk factor in posterior fossa surgery.

Authors:  Concezio Di Rocco; Daniela Chieffo; Paolo Frassanito; Massimo Caldarelli; Luca Massimi; Gianpiero Tamburrini
Journal:  Cerebellum       Date:  2011-09       Impact factor: 3.847

Review 4.  Cerebellar mutism: review of the literature.

Authors:  Thora Gudrunardottir; Astrid Sehested; Marianne Juhler; Kjeld Schmiegelow
Journal:  Childs Nerv Syst       Date:  2011-03       Impact factor: 1.475

5.  Neurocognitive outcome 12 months following cerebellar mutism syndrome in pediatric patients with medulloblastoma.

Authors:  Shawna L Palmer; Tim Hassall; Karen Evankovich; Donald J Mabbott; Melanie Bonner; Cinzia Deluca; Richard Cohn; Michael J Fisher; E Brannon Morris; Alberto Broniscer; Amar Gajjar
Journal:  Neuro Oncol       Date:  2010-08-16       Impact factor: 12.300

Review 6.  Postoperative cerebellar mutism in adult patients with Lhermitte-Duclos disease.

Authors:  Ali Afshar-Oromieh; Heinz Linhart; Dino Podlesek; Wiebke Schrempf; Gabriele Schackert; Dietmar Krex
Journal:  Neurosurg Rev       Date:  2010-07-29       Impact factor: 3.042

7.  Cerebellar mutism syndrome and its relation to cerebellar cognitive and affective function: Review of the literature.

Authors:  Ozlem Yildiz; Serdar Kabatas; Cem Yilmaz; Nur Altinors; Belma Agaoglu
Journal:  Ann Indian Acad Neurol       Date:  2010-01       Impact factor: 1.383

8.  Cerebellar mutism--report of four cases.

Authors:  A Ozimek; S Richter; C Hein-Kropp; B Schoch; B Gorissen; O Kaiser; E Gizewski; W Ziegler; D Timmann
Journal:  J Neurol       Date:  2004-08       Impact factor: 4.849

9.  Clinical-psychological characteristics of children with dysgenesis of the cerebellar vermis.

Authors:  M Yu Bobylova; A S Petrukhin; G N Dunaevskaya; S V Piliya; E S Il'ina
Journal:  Neurosci Behav Physiol       Date:  2007-10

10.  Clinical and neuroanatomical predictors of cerebellar mutism syndrome.

Authors:  Nicole Law; Mark Greenberg; Eric Bouffet; Michael D Taylor; Suzanne Laughlin; Douglas Strother; Christopher Fryer; Dina McConnell; Juliette Hukin; Caelyn Kaise; Frank Wang; Donald J Mabbott
Journal:  Neuro Oncol       Date:  2012-09-05       Impact factor: 12.300

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.